325
Participants
Start Date
September 30, 2012
Primary Completion Date
May 31, 2013
Study Completion Date
July 31, 2013
JTT-851
Glimepiride
Encapsulated Glimepiride tablets
Placebo for Active
Placebo for comparator
Birmingham
Dothan
Huntsville
Montgomery
Muscle Shoals
Glendale
Tucson
Little Rock
Artesia
Beverly Hills
Buena Park
Chino
Garden Grove
Lincoln
Lomita
Los Angeles
Newport Beach
North Hollywood
Paramount
Sacramento
Spring Valley
Walnut Creek
Denver
Cooper City
Fort Lauderdale
Hialeah
Kissimee
Miami
Miramar
Ocala
Orlando
Ormond Beach
Pembroke Pines
Port Orange
Tampa
Columbus
Marietta
Nampa
Chicago
Evanston
Indianapolis
Wichita
Lake Charles
New Orleans
Oxon Hill
Olive Branch
Las Vegas
Berlin
Mine Hill
Glen Falls
Greensboro
Cincinnati
Kettering
Marion
Munroe Falls
Wadsworth
Norman
Oklahoma City
Eugene
Portland
Lansdale
Columbia
Greer
Carrollton
Corpus Christi
Dallas
Houston
Plano
San Antonio
Sugarland
Tomball
Murray
Orem
Salt Lake City
Burke
Manassas
Norfolk
Suffolk
Madison
Lead Sponsor
Akros Pharma Inc.
INDUSTRY